Posted by Gary Schwitzer in Evidence-based medicine, Health care costs, Health care journalism
Bad week on network TV.
Stories on…
• a male contraceptive
all failed to discuss costs, to quantify benefits and harms, or to give independent perspectives.
Viewers of these programs got one-sided, incomplete, imbalanced portrayals of health care treatments, tests, products and procedures.
Comments are closed.
Treatment for advanced ovarian tumors may lengthen survival, but questions still remain, despite the story’s emphasis on “promising” and “new hope.”
As with the HealthDay story on this research that we reviewed, readers of this story get a good dose of caveats and cautions along with the suggestions that electrical brain stimulation might someday “have implications” for treatment of Alzheimer’s disease.
The readers of this story and the other one we reviewed by Reuters are likely to understand that electrical brain stimulation could have some memory effects, but it’s a long way from becoming a treatment for Alzheimer’s disease.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2012 Health News Review
